Joint modeling and marker set selection significantly influence functional biomechanics in end-stage knee osteoarthritis: evidence from the sit-to-stand task

Introduction The sit-to-stand (STS) movement represents a mechanically demanding task, particularly informative in patients with knee osteoarthritis. While three-dimensional optoelectronic motion capture is the gold standard for analyzing joint biomechanics, the influence of protocol selection remains poorly characterized in the context of STS. This study investigated protocol-induced variability in knee kinematics and kinetics by evaluating two widely used marker sets: the anatomical-based IOR and the cluster-based CAST, each combined with either inverse kinematics or a six degrees-of-freedom joint model.Materials and Methods Twenty-four patients (mean age of 67 +/- 5 years and BMI of 28.9 +/- 3.8 kg/m2) with end-stage KOA (Kellgren-Lawrence grade 3 or 4) performed three STS trials, and biomechanical outputs were compared across the four resulting protocols using Mean Absolute Variability (MAV), Mean Absolute Differences (MAD), and Statistical Parametric Mapping (SPM).Results Results revealed substantial variability across protocols, with the highest discrepancies observed in the sagittal plane: peak MAV reached 23.99 degrees for knee flexion angle and 0.24 Nm/kg for knee flexion moment. Frontal and transverse parameters also showed clinically meaningful differences, particularly for knee adduction and internal rotation angles, with MAD values exceeding established thresholds. Differences were amplified when both markers set, and modeling strategy varied. In this context, cluster-based configurations showed reduced variability. SPM analyses revealed temporally localized differences, particularly at the initiation and final stabilization phases of the movement.Conclusion These findings emphasize the critical role of protocol selection in motion analysis and its direct impact on the interpretation of knee biomechanics during functional tasks, highlighting the importance of adopting consistent and robust methodological frameworks to ensure clinical reliability and cross-study comparability.Clinical Trial Registration https://clinicaltrials.gov/, identifier NCT06634654.